The Future Of Organoid Adoption Depends On Context Of Use
The discussion highlighted a fundamental shift underway in the organoid field, moving away from the idea that every new model must be validated against an existing animal benchmark. Instead, both panelists emphasized that the future of adoption will depend on whether a model can answer a specific scientific or regulatory question with sufficient confidence. As Sri Kadambi noted, researchers should avoid focusing on whether organoids can replace animal models outright and instead ask, "What scientific or safety question was the animal study intended to answer?" He argued that organoids, animal models, clinical data, and other experimental systems should be viewed as complementary sources of evidence rather than competing technologies.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.